There are now a number of pharmacological agents that have been documented to increase GLT-1[55–57], however ceftriaxone is the most well characterized and has been tested in mouse models of ALS [58] and is neuroprotective in a variety of CNS injuries [59–61]. The gene discussed is SLC1A2; the disease is amyotrophic lateral sclerosis.